RA Capital Management’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $45.6M | Hold |
|
|||||
|
2024
Q4 | $72.9M | Sell |
|
|||||
|
2024
Q3 | $110M | Hold |
|
|||||
|
2024
Q2 | $108M | Buy |
|
|||||
|
2024
Q1 | $129M | Hold |
|
|||||
|
2023
Q4 | $114M | Hold |
|
|||||
|
2023
Q3 | $95.8M | Hold |
|
|||||
|
2023
Q2 | $93.2M | Buy |
|
|||||
|
2023
Q1 | $94.1M | Hold |
|
|||||
|
2022
Q4 | $152M | Hold |
|
|||||
|
2022
Q3 | $141M | Hold |
|
|||||
|
2022
Q2 | $126M | Buy |
|
|||||
|
2022
Q1 | $60.1M | Buy |
|
|||||
|
2021
Q4 | $83.7M | Hold |
|
|||||
|
2021
Q3 | $118M | Hold |
|
|||||
|
2021
Q2 | $113M | Buy |
|